info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Prils Companies

It appears that you are referring to medications that belong to the class of drugs known as ACE inhibitors, which commonly end in the suffix "pril." ACE inhibitors are widely used in the treatment of various cardiovascular conditions, including hypertension (high blood pressure), heart failure, and chronic kidney disease.

Prils Key CompaniesLatest Prils Companies Update



  • September 2023: A novel generic medication introduced by Pharmascience Canada for the treatment of hypertension. Adults are initially prescribed pms-PERINDOPRIL-INDAPAMIDE (perindopril erbumine/indapamide) to treat essential hypertension ranging from mild to moderate. The PMS-PERINDOPRIL-INDAPAMIDE (perindopril erbumine/indapamide) comprises the angiotensin converting enzyme (ACE) inhibitor perindopril erbumine and the chlorosulfamoyl diuretic indapamide. These two active constituents reduce blood pressure in hypertensive patients of all ages through a synergistic effect. The Pharmascience team is delighted to introduce pms-Perindopril-Indapamide, which is intended for the initial management of hypertension. The accessibility of PMS-Perindopril-Indapamide provides an essential and cost-effective treatment alternative for all Canadian citizens.




  • January 2023: Amazon unveiled a novel prescription drug program that offers subscribers an unlimited number of medications for a fixed fee. This development represents the online retailer's most recent effort to entice customers away from traditional drugstores as major technology companies expand their presence in the healthcare industry. The online retailer RxPass will enable U.S. Prime members to complete an unlimited number of prescriptions for generic medications from a list of over 50 and receive free delivery. Antibiotics amoxicillin and doxycycline, antifungal nystatin, blood pressure medication losartan lisinopril, ramipril, and anti-inflammatory naproxen are included on the list of covered medications. A series of generic medications used to treat mental health disorders such as schizophrenia, bipolar disorder, depression, and anxiety are also included. In addition to broadening its presence in primary care, mental health, and telehealth, the organization is negotiating a nearly $4 billion acquisition of healthcare provider One Medical.


List of Prils Key companies in the market

  • Mylan N.V. (U.S.)

  • MERCK KGaA, (Germany)

  • Lupin (India)

  • Aurobindo Pharma (India)

  • Pfizer (U.S.)

  • Sun Pharmaceuticals (India)

  • Novartis (Switzerland)

  • Canadian Pharmaceuticals (Canada)

  • Manus Aktteva Biopharma LLP (India)

  • Hoffman La Roche (Switzerland)

  • Boehringer Ingelheim International Gmbh (Germany)

  • Teva Pharmaceutical Industries (U.S.)

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.